<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Gynecologic Cancer

Gynecologic Cancer    Vaccinations   

Three Things to Know About the HPV Vaccine and Cervical Cancer

January is Cervical Cancer Awareness Month, and CU Cancer Center member Lindsay Brubaker, MD, wants everyone to be aware of the relationship between cervical cancer and the human papillomavirus (HPV), a sexually-transmitted disease that causes the vast majority of cervical cancers. The current HPV vaccine protects against seven predominant strains of the virus that cause cancer, as well as the two that cause genital warts.


Author Cancer Center | Publish Date January 22, 2021
Full Story

Press Coverage    Gynecologic Cancer

One Of The Youngest Ovarian Cancer Victims Remembered: ‘She Never Stopped Fighting’

Peyton taught the world that ovarian cancer doesn’t just strike mothers and grandmothers. “She’s brought so much awareness to the disease through her advocacy,” said CU Cancer Center member Saketh Guntupalli, MD. 


Author CBS4 Denver | Publish Date January 08, 2021
Full Story

Research    Gynecologic Cancer    ovarian cancer

CU Researchers Come Together to Better Understand Ovarian Cancer Tumors and Treatment Outcomes

After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the composition of ovarian cancer tumors changes during chemotherapy and contributes to therapeutic response.


Author Cancer Center | Publish Date September 15, 2020
Full Story

Research    Gynecologic Cancer   

American Cancer Society Releases Simplified Cervical Cancer Screening Guidelines

Last month the American Cancer Society (ACS) released updated guidelines for cervical cancer screening. The most notable change in guidelines is the changes in the age to begin screening. Per the new guidelines, it is recommended that cervical cancer screening begin at age 25. Previously, the starting age for screening was 21.


Author Cancer Center | Publish Date August 18, 2020
Full Story

Philanthropy    Gynecologic Cancer    Cancer    ovarian cancer

Building Towards Early Detection of Ovarian Cancer

In July 2019, Emily McClintock Addlesperger was on vacation in Maine with her husband, Jason, when she felt sick and was airlifted to Portland with internal bleeding. A tumor on her ovary had burst. It was Monday. On Saturday, she passed away. Emily was 44 years old.


Author Cancer Center | Publish Date July 16, 2020
Full Story

Gynecologic Cancer    Clinical Research

A Slippery Slope to the Operating Room

Brad Corr’s inspiration to pursue a medical career came on the ski slopes of Big Sky, Montana.


Author Cancer Center | Publish Date February 03, 2020
Full Story

Gynecologic Cancer    Women's Health    Advocacy

Cervical cancer survivor: Don’t miss your Pap smears!

Debbie Garcia always dreamed of having a big family.


Author Cancer Center | Publish Date January 17, 2020
Full Story

Gynecologic Cancer

Saketh Guntupalli on leadership vision, higher survival rates for gynecologic cancers

This July, University of Colorado Cancer Center investigator, Saketh Guntupalli, MD, assumes the role of Division Chief of the CU School of Medicine Department of Obstetrics and Gynecology Division of Gynecologic Oncology, with a mission to increase the excellence of clinical care, train the next generation of physician-scientists, and move the needle on gynecologic cancer research. Guntupalli takes over a program that already boasts 15-20 percent improved survival rates over national averages for some cancers including uterine cancer.


Author Cancer Center | Publish Date July 01, 2019
Full Story

Gynecologic Cancer

ASCO: Sexual health interventions after treatment are an unmet need for gynecologic cancer patients

Sexual health can be an uncomfortable subject after completing cancer treatment, but is an important quality of life issue. A University of Colorado Cancer Center study presented at the 2019 American Society of Clinical Oncology (ASCO) conference in Chicago highlights the unmet need of interventions to improve and maintain optimal sexual health. 


Author Cancer Center | Publish Date May 31, 2019
Full Story

Gynecologic Cancer

Take the Tubes but Leave the Ovaries: Salpingectomy an Evolving Option for Young Women at High Risk for Gynecologic Cancers

In women at high risk for ovarian cancer, the common prevention strategy is to remove fallopian tubes and ovaries as soon as the woman is done having a family – the sooner the better. But this initiates menopause and along with it higher risk of cardiovascular disease, osteoporosis, sexual side-effects, and perhaps even Alzheimer’s disease. A recent University of Colorado Cancer Center review in the International Journal of Gynecologic Cancer suggests a way young, high-risk women can reduce risk while leaving menopause for later: the technique known as salpingectomy removes the fallopian tubes while leaving ovaries intact.


Author Garth Sundem | Publish Date February 20, 2013
Full Story

CU Cancer Center In the News

5280

No, Sun Exposure Is Not the Secret to Living Longer (Probably)

news outlet5280
Publish DateJanuary 05, 2022

CU Cancer Center member Neil Box, MD, separates fact from pseudoscience when it comes to protecting yourself from the sun.

Full Story
Denver 7

'I'm Just so Proud of Him': Crested Butte Family Shares 2-year-old's Journey with Kidney Cancer

news outletDenver 7
Publish DateDecember 23, 2021

In 2021, a Crested Butte family received a life-changing diagnosis. During the holiday season, their story is an apparent reminder that sometimes the best gifts are never found under a tree.

Full Story
Cure Today

Triplet Regimen Extends Time Before Brain, Spinal Cord Metastases Worsen in Patients with Breast Cancer

news outletCure Today
Publish DateDecember 15, 2021

A three-drug regimen was shown to lengthen the amount of time before cancer progressed to the central nervous system — known as central nervous system progression-free survival — in certain patients with breast cancer.

Full Story
Healio

Liso-cel Significantly Improves Outcomes in Second-Line DLBCL

news outletHealio
Publish DateDecember 11, 2021

Second-line lisocabtagene maraleucel more than quadrupled EFS compared with standard therapy for patients with relapsed or refractory large B-cell lymphoma, according to study results presented at ASH Annual Meeting and Exposition.

Full Story